Potent, nonsteroidal androgen receptor modulators based on 2-quinolinone scaffolds: A platform for selective androgen receptor modulators (SARMS).

被引:0
|
作者
Higuchi, RI
Zhi, L
Edwards, JP
Caferro, TR
Ringgenberg, JD
West, SJ
Kong, JW
Hamann, LG
Arienti, KL
Cummings, ML
Wu, M
Tegley, CM
Jones, TK
Lopez, FJ
Marschke, KB
Schrader, WT
机构
[1] Ligand Pharmaceut Inc, Med Chem, San Diego, CA 92121 USA
[2] Ligand Pharmaceut Inc, Pharmacol, San Diego, CA 92121 USA
[3] Ligand Pharmaceut Inc, New Leads Discovery, San Diego, CA 92121 USA
[4] Ligand Pharmaceut Inc, Sci & Technol, San Diego, CA 92121 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
5-MEDI
引用
收藏
页码:U537 / U538
页数:2
相关论文
共 50 条
  • [21] Pharmacodynamics of selective androgen receptor modulators
    Yin, DH
    Gao, WQ
    Kearbey, JD
    Xu, HP
    Chung, KW
    He, YL
    Marhefka, CA
    Veverka, KA
    Miller, DD
    Dalton, JT
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 304 (03): : 1334 - 1340
  • [22] Selective androgen receptor modulators: the future of androgen therapy?
    Christiansen, Andrew R.
    Lipshultz, Larry I.
    Hotaling, James M.
    Pastuszak, Alexander W.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 : S135 - S148
  • [23] In vitro metabolic profile of novel nonsteroidal selective androgen receptor modulators
    Press, Barry
    Snyder, Linda
    Reust, Melinda
    Dalton, James T.
    Yuan, Dan Z.
    Veverka, Karen A.
    DRUG METABOLISM REVIEWS, 2006, 38 : 92 - 93
  • [24] Nonsteroidal Selective Androgen Receptor Modulators Enhance Female Sexual Motivation
    Jones, Amanda
    Hwang, Dong Jin
    Duke, Charles B., III
    He, Yali
    Siddam, Anjaiah
    Miller, Duane D.
    Dalton, James T.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (02): : 439 - 448
  • [25] Antiandrogens: selective androgen receptor modulators
    Berrevoets, CA
    Umar, A
    Brinkmann, AO
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 198 (1-2) : 97 - 103
  • [26] Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I
    Aikawa, Katsuji
    Miyawaki, Toshio
    Hitaka, Takenori
    Imai, Yumi N.
    Hara, Takahito
    Miyazaki, Junichi
    Yamaoka, Masuo
    Kusaka, Masami
    Kanzaki, Naoyuki
    Tasaka, Akihiro
    Shiraishi, Mitsuru
    Yamamoto, Satoshi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (10) : 2568 - 2578
  • [27] Structure-activity relationships and scaffold modifications in selective androgen receptor modulators (SARMs)
    Hamann, LG
    Li, J
    Nirschl, A
    Sutton, J
    Simpkins, LM
    Manfredi, M
    Zou, Y
    Pi, ZL
    Huang, YT
    Wang, HX
    Wang, T
    Sun, CQ
    Bi, YZ
    Augeri, DJ
    Johnson, R
    Driscoll, J
    Lupisella, J
    Golla, R
    Seethala, R
    Beehler, B
    Sleph, P
    Egan, D
    Welzel, G
    An, YM
    Krystek, SR
    Fura, A
    Grover, G
    Ostrowski, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2638 - U2639
  • [28] Human hair testing for selective androgen receptor modulators (SARMs): Current knowledge and limitations
    Kintz, Pascal
    Gheddar, Laurie
    Ameline, Alice
    Raul, Jean-Sebastien
    TOXICOLOGIE ANALYTIQUE ET CLINIQUE, 2022, 34 (01) : 83 - 89
  • [29] Synthesis and androgen receptor affinity of several linkages of 1,3-disubstituted-2-hydroxy-2-methylpropionamide selective androgen receptor modulators (SARMs).
    Hwang, DJ
    Kim, J
    Dalton, JT
    Miller, DD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U139 - U139
  • [30] Novel androgen therapies including selective androgen receptor modulators
    Kang, Jungwoo
    Chen, Runzhi
    Tharakan, Tharu
    Minhas, Suks
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 36 (05)